Načítá se...
Can Patients with Type 2 Diabetes Be Treated with AMPK-Activators?
AMP-activated protein kinase (AMPK) has been identified as a target for development of pharmaceuticals for prevention and treatment of type 2 diabetes. Chemical activation of AMPK in experimental animals using 5-aminoimidazole-4-carboxamide (AICAR) has previously been reported to activate AMPK, stim...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2730159/ https://ncbi.nlm.nih.gov/pubmed/18696044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-008-1115-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|